ArticleNeurology and therapy2026

Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings.

Noah Rosen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.